New antibiotic tested in kids: a step toward better infection control

NCT ID NCT02134301

First seen Dec 12, 2025 · Last updated May 13, 2026 · Updated 20 times

Summary

This early-stage study tested a single dose of oritavancin in 41 children under 18 with suspected or confirmed bacterial infections. The goal was to see how the drug moves through the body and whether it is safe. Results will help guide future use of this antibiotic in pediatric patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GRAM-POSITIVE BACTERIAL INFECTIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Arkansas Children's Hospital

    Little Rock, Arkansas, 72202, United States

  • Children's Hospital of Orange County

    Orange, California, 92868, United States

  • Rady Children's Hospital

    San Diego, California, 92123, United States

  • Rainbow Babies and Children's Hospital

    Cleveland, Ohio, 44106, United States

  • Toledo Children's Hospital

    Toledo, Ohio, 43606, United States

  • UCLA Harbor Medical Center

    Torrance, California, 90502, United States

  • Univ of Louisville, Norton Children's Research Institute

    Louisville, Kentucky, 40202, United States

  • University of Nebraska Medical Center

    Omaha, Nebraska, 68114, United States

Conditions

Explore the condition pages connected to this study.